Indications |
Oral Anxiety Adult: Usual dose: 1-6 mg daily in 2 or 3 divided doses. Largest dose taken at night. Up to 10 mg daily has been used. Elderly: Initial dose of 1-2 mg daily in 2 or 3 divided doses. Adjust as necessary. Oral Insomnia associated with anxiety Adult: 1-4 mg as a single dose given at bedtime. Elderly: 1-2 mg initially, adjust as needed. Oral Premedication in surgery Adult: 2-3 mg given the night before the operation followed by a smaller dose if necessary, the next morning. Alternatively, 2-4 mg is given 1-2 hr before the operation. Child: 1 mth-12 yr: 0.05-0.1 mg/kg (max: 4 mg) given at least 1 hr before surgery. Same dose may be given the night before either as an addition to or to replace the pre-operative dose. Oral Prophylaxis of nausea and vomiting associated with cytotoxic therapy Adult: For moderately emetogenic chemotherapy: May add 1-2 mg to the antiemetic therapy with domperidone or metoclopramide. Parenteral Acute anxiety Adult: 25-30 mcg/kg repeated every 6 hr if necessary. Dose may be given via IV or IM inj. Give IV inj at a rate of not >2 mg/minute into a large vein. Child: Usual: 50 mcg/kg every 4-8 hr. Intravenous Status epilepticus Adult: 4 mg injected slowly, may repeat once after 10 minutes if seizures recur. Dose should be given at a rate not >2 mg/minute into a large vein. Child: Neonates and children up to 12 yr: 0.1 mg/kg (max: 4 mg) as a single dose, may repeat once after 10 minutes if needed. Parenteral Premedication in surgery Adult: 50 mcg/kg, to be given 30-45 minutes before the operation if given via IV inj or 1-1.5 hr before operation if given via IM inj. Intravenous Sedation in critical care Adult: 0.02-0.06 mg/kg every 2-6 hr as inj or 0.01-0.1 mg/kg/hr as continuous IV infusion. Child: ≥2 mth: 0.025-0.05 mg/kg (max 2 mg) every 2-4 hr as intermittent IV infusion or 0.025 mg/kg/hr (to a max of 2 mg/hr) as continuous IV infusion. |
Contraindications |
Severe hepatic impairment; respiratory depression; acute narrow-angle glaucoma; pregnancy and lactation. |
Warnings / Precautions |
Hepatic and renal dysfunction; pulmonary insufficiency; myasthenia gravis; may impair ability to drive or operate machinery; elderly or debilitated patients. |
Adverse Reactions |
Drowsiness, headache, dizziness, confusion; blurred vision; nausea; weakness; unsteadiness. Potentially Fatal: Respiratory depression. |
Overdose Reactions |
The main symptom of overdosage is excessive CNS depression. Treatment is generally supportive but flumazenil may also be used in hospitalised patients if the benefits are thought to outweigh the risk of seizure. |
Drug Interactions |
Potentiation of CNS depression produced by alcohol; general anaesthetics; narcotic analgesics; TCAs; MAOIs; phenothiazines; antipsychotics; barbiturates; scopolamine. See Below for More lorazepam Drug Interactions |
Mechanism of Actions |
Lorazepam is a short acting benzodiazepine. Lorazepam enhances the inhibitory effect of GABA on neuronal excitability by modulating GABAA receptors. Onset: Hypnosis: 20-30 min (IM); sedation: 5-20 min (IV); anticonvulsant: 5 min (IV), 30-60 min (oral). Duration: 6-8 hr. Absorption: Readily absorbed (oral, IM); peak plasma concentrations after 2 hr. Distribution: Crosses the placenta and blood-brain barrier; enters breast milk. Protein-binding: 85%. Metabolism: Hepatic; converted to inactive metabolites. Excretion: Urine and faeces; 10-20 hr (elimination half-life). |
Administration |
May be taken with or without food. |
ATC Classification |
N05BA06 - lorazepam ; Belongs to the class of benzodiazepine derivatives anxiolytics. Used in the management of anxiety, agitation or tension. |
Available As |
|
Lorazepam
Post Review about Lorazepam Click here to cancel reply.
Lorazepam Containing Brands
Lorazepam is used in following diseases
Drug - Drug Interactions of Lorazepam
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.